8.20p-0.80 (-8.89%)25 Apr 2024, 16:35
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Oxford Biodynamics PLC Fundamentals

Company NameOxford Biodynamics PLCLast Updated2024-04-25
IndustryBiotechnologySectorHealthcare
Shares in Issue311.856 mMarket Cap£25.57 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.07EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.3993Debt Equity Ratio0.9283
Asset Equity Ratio2.6634Cash Equity Ratio0.8671
Quick Ratio1.5514Current Ratio1.79
Price To Book Value4.6361ROCE0

Oxford Biodynamics PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Oxford Biodynamics PLC Company Financials

Assets202320222021
Tangible Assets£7.00 m£6.98 m£7.55 m
Intangible Assets£1.91 m£1.60 m£1.15 m
Investments000
Total Fixed Assets£8.96 m£8.58 m£8.70 m
Stocks£274,000.00£337,000.00£392,000.00
Debtors£957,000.00£509,000.00£980,000.00
Cash & Equivalents£5.25 m£999,000.00£4.34 m
Other Assets000
Total Assets£16.13 m£11.34 m£15.38 m
Liabilities202320222021
Creditors within 1 year£4.00 m£2.91 m£2.29 m
Creditors after 1 year£6.07 m£5.84 m£6.39 m
Other Liabilities000
Total Liabilities£10.07 m£8.76 m£8.69 m
Net assets£6.05 m£2.59 m£6.69 m
Equity202320222021
Called up share capital£2.02 m£1.00 m£926,000.00
Share Premium£32.14 m£19.02 m£16.74 m
Profit / Loss-£11.41 m-£7.57 m-£7.63 m
Other Equity£6.05 m£2.59 m£6.68 m
Preference & Minorities00£17,000.00
Total Capital Employed£6.05 m£2.59 m£6.69 m
Ratios202320222021
Debt Ratio£0.48£0.68£0.47
Debt-to-Equity£0.93£2.09£0.89
Assets / Equity2.66342.66342.6634
Cash / Equity0.86710.86710.8671
EPS-£0.07-£0.08-£0.07
Cash Flow202320222021
Cash from operating activities-£8.29 m-£5.18 m-£5.92 m
Cashflow before financing£4.91 m-£2.62 m-£6.72 m
Increase in Cash£4.29 m-£1.36 m-£3.90 m
Income202320222021
Turnover£510,000.00£154,000.00£341,000.00
Cost of sales£244,000.00£38,000.000
Gross Profit£266,000.00£116,000.00£341,000.00
Operating Profit-£10.17 m-£8.60 m-£7.51 m
Pre-Tax profit-£11.41 m-£7.57 m-£7.63 m

Oxford Biodynamics PLC Company Background

SectorHealthcare
ActivitiesOxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.
Latest Interim Date30 May 2023
Latest Fiscal Year End Date17 Jan 2024

Oxford Biodynamics PLC Directors

AppointedNamePosition
2019-03-13Mr. David Jefferys WilliamsNon-Executive Director,Chairman
2023-10-23Dr. David Mark Anthony HolbrookNon-Executive Director
2020-12-30Mr. Christian Gurth Hoyer Millar Executive Director
2024-04-10Dr. Alexandre Akoulitchev Executive Director,Chief Scientific Officer
2024-04-10Mr. Stephen Charles Diggle Non-Executive Director
2024-04-10Mr. Paul Leslie StockdaleExecutive Director,Chief Financial Officer
2020-12-14Mr. Peter Pack Non-Executive Director,Chairman
2024-04-10Dr. Jon Anthony Joseph BurrowsExecutive Director,Group Chief Executive Officer
2024-04-10Mr. Matthew Anthony WakefieldNon-Executive Director,Chairman

Oxford Biodynamics PLC Contact Details

Company NameOxford BioDynamics PLC
Address26 Beaumont Street, Oxford, OX1 2NP
Telephone+44 1865518910
Websitehttps://www.oxfordbiodynamics.com

Oxford Biodynamics PLC Advisors

StockbrokerShore Capital Stockbrokers Ltd
Phone+44 2074084050
Fax+44 2074084091
BankHSBC Bank PLC
SolicitorMayer Brown International LLP
Phone+44 2031303000
Fax+44 2031303001
AuditorKPMG
Phone+44 1189642000
Fax+44 1189642222
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
Nominated AdviserStifel Nicolaus Europe Ltd
Phone+44 2077107600
Fax+44 2077107609
StockbrokerStifel Nicolaus Europe Ltd
Phone+44 2077107600
Fax+44 2077107609
Financial PR AdviserConsilium Strategic Communications
Phone+44 2037095700